0001213900-26-098803.txt : 20260910 0001213900-26-098803.hdr.sgml : 20260910 20260910161522 ACCESSION NUMBER: 0001213900-26-098803 CONFORMED SUBMISSION TYPE: D PUBLIC DOCUMENT COUNT: 1 ITEM INFORMATION: Rule 506(b) provides a "safer harbor" for a private offering FILED AS OF DATE: 20260910 DATE AS OF CHANGE: 20260910 EFFECTIVENESS DATE: 20260910 FILER: COMPANY DATA: COMPANY CONFORMED NAME: Polyrizon Ltd. CENTRAL INDEX KEY: 0001893645 STANDARD INDUSTRIAL CLASSIFICATION: SURGICAL & MEDICAL INSTRUMENTS & APPARATUS [3841] ORGANIZATION NAME: 08 Industrial Applications and Services EIN: 000000000 STATE OF INCORPORATION: L3 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: D SEC ACT: 1933 Act SEC FILE NUMBER: 021-597061 FILM NUMBER: 261371270 BUSINESS ADDRESS: ADDRESS IS A NON US LOCATION: YES STREET 1: HAPNINA ST 8 CITY: RA'ANANA PROVINCE COUNTRY: L3 ZIP: 4321545 BUSINESS PHONE: 972-54-7979668 MAIL ADDRESS: ADDRESS IS A NON US LOCATION: YES STREET 1: HAPNINA ST 8 CITY: RA'ANANA PROVINCE COUNTRY: L3 ZIP: 4321545 D 1 primary_doc.xml X0708 D LIVE 0001893645 Polyrizon Ltd. 8 HAPNINA STREET RAANANA L3 ISRAEL 4321545 +972-9-3740120 ISRAEL None None Corporation true Tomer Izraeli POLYRIZON LTD. 8 HaPnina Street Raanana L3 ISRAEL 4321545 Executive Officer Director Chief Executive Officer and Director Nir Ben Yosef POLYRIZON LTD. 8 HaPnina Street Raanana L3 ISRAEL 4321545 Executive Officer Chief Financial Officer Eyal Ron POLYRIZON LTD. 8 HaPnina Street Raanana L3 ISRAEL 4321545 Executive Officer Chief Science Officer Tidhar Turgeman POLYRIZON LTD. 8 HaPnina Street Raanana L3 ISRAEL 4321545 Executive Officer Chief Technology Officer Asaf Itzhaik POLYRIZON LTD. 8 HaPnina Street Raanana L3 ISRAEL 4321545 Director Oz Adler POLYRIZON LTD. 8 HaPnina Street Raanana L3 ISRAEL 4321545 Director Liat Sidi POLYRIZON LTD. 8 HaPnina Street Raanana L3 ISRAEL 4321545 Director Yehonatan Zalman Vinokur POLYRIZON LTD. 8 HaPnina Street Raanana L3 ISRAEL 4321545 Director Liron Carmel POLYRIZON LTD. 8 HaPnina Street Raanana L3 ISRAEL 4321545 Director Biotechnology Decline to Disclose 06b false 2026-09-03 false true true false 0 Aegis Capital Corp. 000015007 None None 1345 Avenue of the Americas 27th Floor New York X1 UNITED STATES 10105 All States false 3999996 3999996 0 The warrants and shares were issued in connection with (i) a registered direct offering of 232,500 shares and pre-funded warrants for 30,000 shares, and (ii) a private placement of pre-funded warrants for 70,833 shares and warrants for 333,333 shares. false 1 320000 0 Aegis Capital Corp. is entitled to a cash placement fee equal to 8.0% of the gross proceeds received in the offering and $75,000 for reasonable legal fees and disbursements for its counsel. 0 The Company intends to use the net proceeds, together with existing cash, for general corporate purposes, including financing operations, capital expenditures, business development and technology development, and pursuing strategic opportunities. false Polyrizon Ltd. /s/ Tomer Izraeli Tomer Izraeli Chief Executive Officer 2026-09-10